Improved response in high-risk neuroblastoma with protracted topotecan administration using a pharmacokinetically guided dosing approach.

Source:http://linkedlifedata.com/resource/pubmed/id/15961757

J. Clin. Oncol. 2005 Jun 20 23 18 4039-47

Download in:

View as

General Info

PMID
15961757